Yasue Shibata

Title: Yasue Shibata: Innovator in Monoclonal Antibody Development

Introduction

Yasue Shibata is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of two patents to his name, Shibata's work is recognized for its potential impact on medical research and treatment.

Latest Patents

Shibata's latest patents include innovative developments in the area of anti-human receptor-type protein tyrosine phosphatase sigma antibodies. The first patent describes polynucleotides encoding these antibodies, which bind to an extracellular domain of human receptor-type protein tyrosine phosphatase sigma (human PTPRS). The second patent focuses on a monoclonal antibody that also targets the extracellular domain of human PTPRS, or a fragment that includes an antigen-binding region.

Career Highlights

Yasue Shibata is currently associated with Sbi Biotech Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention in the scientific community, contributing to the understanding of protein interactions and their implications in various diseases.

Collaborations

Shibata collaborates with esteemed colleagues, including Tomohide Yamazaki and Jing Zhao, who bring diverse expertise to their projects. These collaborations enhance the research environment and foster innovation in their respective fields.

Conclusion

Yasue Shibata's contributions to monoclonal antibody research exemplify the importance of innovation in biotechnology. His patents reflect a commitment to advancing medical science and improving therapeutic options.